Literature DB >> 33108677

Melatonin controversies, an update.

Jean A Boutin1, Ralf Jockers2.   

Abstract

Melatonin was discovered more than 60 years ago. Since then, several seminal discoveries have allowed us to define its function as a neuroendocrine hormone and its molecular targets in mammals and many other species. However, many fundamental issues have not yet been solved such as the subcellular localization of melatonin synthesis and the full spectrum of its molecular targets. In addition, a considerable number of controversies persist in the field, mainly concerning how many functions melatonin has. Altogether, this illustrates how "immature" the field still is. The intention of this opinion article is to note the controversies and limitations in the field, to initiate a discussion and to make proposals/guidelines to overcome them and move the field forward.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer disease; COVID-19; GPCR; antioxidant; melatonin

Year:  2020        PMID: 33108677     DOI: 10.1111/jpi.12702

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

1.  MT1 Receptor Signaling Pathways by Impedance Measurement.

Authors:  Anne Bonnaud; Clémence Dupré; Céline Legros; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

2.  Why Are We Still Cloning Melatonin Receptors? A Commentary.

Authors:  Célia Gautier; Isabelle Theret; Giulia Lizzo; Gilles Ferry; Sophie-Pénélope Guénin; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

3.  Detection of Melatonin in Tissue Samples.

Authors:  Céline Legros; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

4.  Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels.

Authors:  Erika Cecon; Daniela Fernandois; Nicolas Renault; Caio Fernando Ferreira Coelho; Jan Wenzel; Markus Schwaninger; Vincent Prevot; Julie Dam; Ralf Jockers; Corentin Bedart; Charlotte Izabelle; Sarah Gallet; Sophie Le Poder; Bernard Klonjkowski
Journal:  Cell Mol Life Sci       Date:  2022-06-13       Impact factor: 9.207

5.  Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2.

Authors:  Erika Cecon; Charlotte Izabelle; Sophie Le Poder; Fernando Real; Aiwei Zhu; Ly Tu; Maria Rosa Ghigna; Bernard Klonjkowski; Morgane Bomsel; Ralf Jockers; Julie Dam
Journal:  J Pineal Res       Date:  2021-10-15       Impact factor: 12.081

Review 6.  Nanotechnology-based advances in the efficient delivery of melatonin.

Authors:  Mohammad Mirza-Aghazadeh-Attari; Ainaz Mihanfar; Bahman Yousefi; Maryam Majidinia
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

7.  Constituents of Chamaecrista diphylla (L.) Greene Leaves with Potent Antioxidant Capacity: A Feature-Based Molecular Network Dereplication Approach.

Authors:  Paulo Gomes; Luis Quirós-Guerrero; Abraão Muribeca; José Reis; Sônia Pamplona; Anderson H Lima; Mariele Trindade; Consuelo Silva; Jesus N S Souza; Jean Boutin; Jean-Luc Wolfender; Milton Silva
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321

8.  N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability.

Authors:  Francesca Ferlenghi; Michele Mari; Gabriella Gobbi; Gian Marco Elisi; Marco Mor; Silvia Rivara; Federica Vacondio; Silvia Bartolucci; Annalida Bedini; Fabiola Fanini; Gilberto Spadoni
Journal:  ChemMedChem       Date:  2021-07-26       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.